Genmab — Oktober 2020
-
-
Servicemeddelelse: Vi arbejder på ændringer på sitet i aften og i nat. Beklager eventuel nedetid.
-
PS: enig Solsen.
-
God morgen. :-9
-
God morgen.
-
Servicemeddelelse: Proinvestor har indgået nyt partnerskab med FinanceLab på analysesiden: http://www.financelab.dk/ipa/
-
J&J's next-gen Darzalex sparks drug delivery royalties battle https://www.fiercepharma.com/pharma/genmab-takes-j-j-to-arbitration-court-over-subq-darzalex-royalties?utm_campaign=coschedule&utm_source=twitter&utm_medium=AmaroLawFirm
-
Multiple Myeloma Hub
@MM_Hub
·
42 min
Read the latest updates on quadruplet therapy for newly diagnosed MM, here: https://buff.ly/2BOcOXe -
Anyway Stockbull - tror jeg Genmab vinder striden med JNJ
-
God morgen.
-
Muzaffar Qazilbash
@Transplant_Doc
·
8 t
Incorporating daratumumab to backbone regimens may be associated with improved PFS among patients with newly diagnosed HRMM or relapsed or refractory HRMM https://ja.ma/2GuKD1w -
MD fra Riget snakker om Tisotumab https://youtu.be/GHtLIsH71HU (2:56)
-
Multiple Myeloma Hub
@MM_Hub
CONGRESS | #COMy20 | The afternoon session of the virtual #COMyCongress starts with Saad Usmani @szusmani
, @LevineCancer
, introducing anti-CD38-based combinations as a therapy for patients with relapsed/refractory https://twitter.com/MM_Hub/status/1312730338557296640 -
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind